InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in InflaRx N.V. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +1 vs. Q4 2024
- Shares held
- 17.5M
- +4.52M (+34.8%) vs. Q4 2024
- Total value
- $17.9M
- −$14.2M (−44.3%) vs. Q4 2024
- New holders
- 11
- 7 more added
- Sold out
- 10
- 5 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IFRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 62 | $211.6M |
| Q1 2026 | 35 | $16.9M |
| Q4 2025 | 34 | $19.6M |
| Q3 2025 | 27 | $24.9M |
| Q2 2025 | 27 | $13.3M |
| Q1 2025 | 31 | $17.9M |
| Q4 2024 | 30 | $32.1M |
| Q3 2024 | 27 | $19.7M |
| Q2 2024 | 33 | $23.0M |
| Q1 2024 | 37 | $21.3M |
| Q4 2023 | 39 | $27.8M |
| Q3 2023 | 42 | $56.8M |
| Q2 2023 | 37 | $82.7M |
| Q1 2023 | 25 | $7.08M |
| Q4 2022 | 33 | $11.6M |
| Q3 2022 | 30 | $10.5M |
| Q2 2022 | 27 | $7.63M |
| Q1 2022 | 32 | $12.0M |
| Q4 2021 | 38 | $44.1M |
| Q3 2021 | 35 | $23.0M |
| Q2 2021 | 37 | $33.1M |
| Q1 2021 | 42 | $56.4M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding InflaRx N.V.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 6,483,910 | $6.61M | 0.27% | +750,000+13.1% | Added |
| 683 Capital Management, LLC | 2,625,000 | $2.68M | 0.27% | +555,000+26.8% | Added |
| Eversept Partners, LP | 1,675,978 | $1.71M | 0.19% | +1,183,526+240.3% | Added |
| Morgan Stanley | 1,261,652 | $1.29M | 0.00% | −776,514−38.1% | Reduced |
| Silverarc Capital Management, LLC | 1,161,567 | $1.18M | 0.25% | +1,161,567 | New |
| Woodline Partners LP | 750,984 | $766.0K | 0.00% | +750,984 | New |
| StemPoint Capital LP | 725,019 | $739.5K | 0.24% | +725,019 | New |
| Raymond James Financial Inc | 632,204 | $644.8K | 0.00% | −5,888−0.9% | Reduced |
| Northern Trust Corp | 618,903 | $631.3K | 0.00% | −47,942−7.2% | Reduced |
| DAFNA Capital Management LLC | 450,000 | $459.0K | 0.13% | +450,000 | New |
| Citadel Advisors LLC | 432,822 | $441.5K | 0.00% | +381,908+750.1% | Added |
| Boothbay Fund Management, LLC | 158,058 | $161.2K | 0.01% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 106,500 | $109.0K | 0.00% | −5,000−4.5% | Reduced |
| Franklin Street Advisors Inc | 75,100 | $77.0K | 0.01% | 00.0% | Unchanged |
| UBS Oconnor LLC | 58,073 | $59.2K | 0.00% | −567,516−90.7% | Reduced |
| Squarepoint Ops LLC | 53,513 | $54.6K | 0.00% | +41,884+360.2% | Added |
| Birchview Capital, LP | 50,000 | $51.0K | 0.04% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 48,136 | $49.1K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 37,528 | $38.3K | 0.00% | +37,528 | New |
| Cubist Systematic Strategies, LLC | 30,053 | $30.7K | 0.00% | +7,616+33.9% | Added |
| Pacifica Partners Inc. | 20,585 | $21.8K | 0.01% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 21,100 | $21.5K | 0.00% | +800+3.9% | Added |
| Quadrature Capital Ltd | 13,858 | $14.4K | 0.00% | +13,858 | New |
| Alyeska Investment Group, L.P. | 13,538 | $13.8K | 0.00% | +13,538 | New |
| HRT Financial LP | 10,724 | $10.0K | 0.00% | +10,724 | New |
| Wells Fargo & Company | 2,000 | $2.04K | 0.00% | +2,000 | New |
| GWM Advisors LLC | 1,400 | $1.43K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,301 | $1.33K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 550 | $561 | 0.00% | +550 | New |
| Deutsche Bank AG | 200 | $204 | 0.00% | +200 | New |
| Stonebridge Financial Group, LLC | 35 | $36 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 0 | $0 | 0.00% | −67,441−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −20,842−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −20,691−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −19,716−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,461−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −10,344−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −3,848−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1,058−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −460−100.0% | Sold out |